Jonathon Thierer

Eversana, SVP of Product

2025 — Present

In 2026, Eversana acquired Waltz Health. Combined, they are totally unique in the pharmaceutical industry; delivering end-to-end commercialization services from Market Access, to Agency, to Payor Services. On top of that foundation, we are building the only AI Platform for pharmaceutical commercialization. Together, we will improve patient experiences, health, and economic outcomes. For Pharma, we drive greater script uptake and adherence while bursting the gross-to-net bubble.

I am responsible for product strategy, design, and development across the enterprise.

Waltz Health, Co-Founder and SVP of Product

2021—2025 (Acquired by EVERSANA)

Waltz Health was founded to rewire prescription care for patients. Waltz builds AI-powered marketplaces to create competition, drive down costs, and improve access. Designed for payers, pharmacies, and patients alike, our solutions bring greater transparency, affordability, and choice to prescription care.

The Wharton School at University of Pennsylvania, MBA in Health Care Management and Data Analytics

2019 — 2021

Educational highlight — 1st Place in the Humana-Mays Healthcare Data Analytics Competition.

Machine learning application and business design for the identification and servicing of patients who have the highest likelihood of facing transportation difficulties and preventing critical care.

In-term work including formulary optimization for value-based care reconciliation at Cedar Gate, product management for Artificial Intelligence at Eversana, and Healthcare Data Analytics curriculum for the Wharton School.

Network Management

2016 — 2019

Responsible for managing drug pricing against PBM contracts with payors and pharmacies.

Developed new approaches to the optimization of non-linear, non-continuous functions by rotating loss functions. Multiple loss functions which map the same economic outcomes but each omit dimensions enable the optimizer to continue descent when it reaches a non-continuous point.

Co-Founder and General Director

2014 — 2016

A disruptive opera company hailed by Opera News as a “Game Changer”, Venture Opera delivered site-specific productions as social events for a younger generation. We produced classics of the repertoire including Don Giovanni, Carmen, and Don Pasquale.